Miami Biotech Collective Enhances Leadership Structure
The Miami Biotech Collective (MBC) has recently expanded its leadership framework with the introduction of a Board of Advisors and a Women's Leadership Council. This initiative aims to fortify collaboration, enhance visibility, and drive growth within South Florida's biotechnology sector. Raquel Cabo, the founder and president of MBC, emphasizes that these newly formalized groups will consolidate diverse expertise to create a significant impact in the biotech ecosystem of the region.
Board of Advisors
The newly formed Board of Advisors comprises an accomplished group of leaders from various sectors of biotechnology and pharmaceuticals:
- - Raquel Cabo, MSc: As the founder of MBC, Raquel brings over 20 years of biopharma experience, having served in various strategic leadership roles at organizations like Ovid Therapeutics, GE Healthcare, and Medtronic.
- - Rich Daly, MBA: The CEO of Catalyst Pharmaceuticals, Rich has over 25 years of experience in pharma and biotech, spearheading transformative therapies.
- - Daniel Teper, PharmD, MBA: CEO of Naya Therapeutics, Daniel is a serial entrepreneur with a wealth of experience in founding and leading biotech firms.
- - James Sapirstein, MBA: With over 39 years in the industry, James has held numerous leadership positions, including the founding CEO of Tobira Therapeutics.
- - Scott Braunstein, MD: Former CEO of Marinus Therapeutics, Scott brings expertise in clinical practice and investment leadership.
- - Sean Ryan, MD: CBO of Mitsubishi Tanabe Pharma, Sean’s background includes significant experience in strategy and business development.
- - Carolina Alarco: Co-Founder of Latinos in Bio, Carolina focuses on advising startups in biotech and medtech.
- - David Schull: With three decades of healthcare communication experience, David helps companies effectively communicate within the biotech landscape.
- - Ignacio Guerrero-Ros, Ph.D.: A vice president at Russo Partners, Ignacio merges scientific acumen with communications strategy.
- - David Moss, MBA: Co-Founder of INmune Bio, David has extensive experience in founding and funding biotech firms.
The collaboration among these experienced professionals intends to build a robust and innovative biotech ecosystem in South Florida.
Women's Leadership Council
In addition to the Board of Advisors, the Women’s Leadership Council has been formed to empower women leaders in the biotech sector:
- - Courtney Miller, Ph.D.: CEO of Myosin Therapeutics, Courtney specializes in neuroscience and drug development.
- - Julie Kampf: Julie is a business executive known for her advocacy in diversity and women’s advancement in life sciences.
- - Christina Trojel-Hansen, Ph.D.: An innovator in life sciences and entrepreneur, Christina has a stellar record in biotech ventures.
- - Rose Satz: Founder of AIP, Rose has over two decades in advancing pharmaceutical innovations.
- - Cantillon Endara, MA: Oncology Account Specialist at Pfizer, Cantillon focuses on driving patient-centric solutions in oncology care.
- - Nidia Martinez Quezada, MA: An advisor with experience in economic growth, Nidia’s role at the Miami-Dade Beacon Council is crucial for investment policy.
- - Cecilia Gonzalo, MBA: A partner at Oberland Capital, Cecilia leads healthcare innovation initiatives.
This Council aims to promote women's representation and leadership within the biotech community while enhancing collaborations and opportunities for professional growth.
About Miami Biotech Collective
MBC is recognized as South Florida's largest and most influential biotechnology community, uniting biotech executives, academic institutions, and public-sector champions. The Collective works hard to create a thriving environment conducive to innovation, career advancement, and company success through various initiatives and events. By positioning South Florida as a burgeoning hub for biotechnology, MBC strives to bring transformational change to the region’s biotech landscape.
For more information about Miami Biotech Collective, visit
www.miamibiotechcollective.com and follow them on LinkedIn.
Contact:
Email: [email protected]
Phone: 646-647-6553
- - Ignacio Guerrero-Ros, Ph.D.
or
David Schull
Russo Partners, LLC
Email: [email protected], [email protected]
Phone: (858) 717-2310 or (646) 942-5604